| Article
Conclusions from new research conducted by a team from University of West Virginia School of Pharmacy and colleagues may help to inform prescribers’ decision making about the engagement of opioid therapy for noncancer pain. In seeking to better understand the risk factors for transitioning to long...
| Podcast
This session will explore some of the challenges resulting from the recent “Decade of Pain.” Clearly, the overuse of opioids and, to some extent, the solutions proposed to curtail the misuse of prescription drugs has led to a shift in how we diagnose and how we treat substance use disorders in this...
| Podcast
2016 was not a good year to be on the wrong side of medical necessity when it came to drug testing and ongoing prescribing of controlled medication or substance abuse treatment programs. 2017 is likely to be an expensive year for those who do not proactively take steps to understand medical...
| Article
Last week, US Surgeon General Jerome Adams, MD, MPH, issued an advisory advocating for greater distribution and availability of naloxone as an element of the national response to opioid use disorder. The Surgeon General recommends that individuals at risk for opioid overdose, as well as their family...
| Article
In 2017, the state of Kentucky became the first to classify gabapentin as a Schedule 5 substance, following the finding that the drug was involved in up to 33% of overdose fatalities during the prior year. This means that prescriptions for gabapentin will be reported to the state’s PDMP going...
| Article
Because they are likely to be at the scene of an overdose when it occurs, fellow drug users may be the most suitable targets for naloxone training, according to conclusions from a new study conducted at Johns Hopkins Bloomberg School of Public Health. In interviews with 450 drug users in the...
| Article
A new study conducted by researchers from the University at Buffalo School of Nursing is one of the first to focus specifically on the risk factors for opioid misuse in older adults. This population is particularly sensitive to adverse effects from opioids, according to the researchers. Study author...
| Article
Although human trials of a new compound developed by Eli Lily and Co. for the treatment of osteoarthritis failed to demonstrate efficacy, the drug may still have substantial utility in the pain management armamentarium. Findings from a study conducted by researchers from Indiana University suggest...
| Podcast
Although opioids remain an important tool in aiding the management of pain in the United States, the balance between the potential benefits and harms must be considered. Some specific harms are manifested in the abuse of opioids for nonmedical purposes. The primary access to prescribable opioids for...
Pagination
- Previous page
- Page 6
- Next page